Why 10,000 Aussies a year being forced to fund their own cancer treatment

21 July 2024 - Australia’s medicine subsidy scheme is so crippled that a staggering 10,000 patients a year are being forced ...

Read more →

Public Summary Documents (first time decisions not to recommend and deferrals) - March 2024 PBAC meeting

19 July 2024 - The Public Summary Documents (first time decisions not to recommend and deferrals) from the March 2024 ...

Read more →

DUSC utilisation analysis public release documents (June 2024)

19 July 2024 - The utilisation analysis public release documents from the June 2024 DUSC meeting are now available. ...

Read more →

Outcome statement - June 2024 DUSC meeting

19 July 2024 - The outcome statement from the June 2024 DUSC meeting is now available. ...

Read more →

Australian children with neuroblastoma given free access to 500,000 dollar cancer drug DFMO

10 July 2024 - Australian children and young adults with neuroblastoma, a cancer that affects the nervous system, will be ...

Read more →

Updates to the HTA Policy and Methods Review

10 July 2024 - The Health Technology Assessment (HTA) Policy and Methods Review concluded on 4 May 2024. The HTA ...

Read more →

Post-market review workplan (May 2024)

8 July 2024 - The post-market review workplan was considered by the PBAC at its intracycle meeting in May 2024. ...

Read more →

Public Summary Documents – March 2024 PBAC meeting (round 1)

5 July 2024 - The Public Summary Documents (positive recommendations and subsequent decisions not to recommend) from the March 2024 PBAC ...

Read more →

New and expanded PBS listings for breast cancer, leukaemia and lupus treatments

2 July 2024 - Australians with early breast cancer, leukaemia, and types of lupus, and insomnia, will now have access to ...

Read more →

DoH publishes revised agenda for July 2024 PBAC meeting (1 July 2024)

1 July 2024 - Version 5 of the agenda for the July 2024 PBAC meeting is now available; one major change. ...

Read more →

Schedule of Pharmaceutical Benefits - 1 July 2024

1 July 2024 - The July 2024 issue of the Schedule of Pharmaceutical Benefits is out and now in effect. ...

Read more →

2024-25 cost recovery implementation statement for listing medicines on the PBS and designated vaccines on the NIP

28 June 2024 - 2024-25 PBS) and NIP cost recovery fees commence on 1 July 2024. ...

Read more →

DoH publishes revised agenda for July 2024 PBAC meeting (21 June 2024)

21 June 2024 - Version 4 of the agenda for the July 2024 PBAC meeting is now available; four minor ...

Read more →

Update from the PBAC (June 2024)

25 June 2024 - As newly appointed Chair of the PBAC, I would like to take the opportunity to establish ...

Read more →

Expanded PBS listings for lung cancer and a chronic skin disease

24 June 2024 - Australians with non-small cell lung cancer and the chronic skin disease hidradenitis suppurativa, now have access to ...

Read more →